Skip to main content
Equibles

PRIMECAP MANAGEMENT CO/CA/

Position in BBIO — BridgeBio Pharma, Inc.

CIK 763212 PASADENA, CA
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$75,670,190
+$33,402,884 QoQ
Shares Held
1,015,980
+78.5% QoQ
Ownership
0.520%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#47
of 472 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRIMECAP MANAGEMENT CO/CA/ holds $3,557,107,452 across 15 Biotechnology names. BBIO ranks #8 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 5,007,931 $1,427,110,097
2 BMRN
Biomarin Pharmaceutical Inc
 14,190,183 $811,962,271
3 RYTM
Rhythm Pharmaceuticals, Inc.
 3,168,853 $351,837,748
4 BNTX
BioNTech SE
 3,772,031 $350,987,484
5 XNCR
Xencor Inc
 10,181,322 $163,919,284
6 IMCR
Immunocore Holdings plc
 3,638,241 $115,514,151
7 IMNM
Immunome Inc.
 4,581,431 $97,080,522
8 BBIO
BridgeBio Pharma, Inc.
This page 		1,015,980 $75,670,190

All Filings in BBIO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,670,190 1,015,980
2026-03-31 $42,267,306 569,180
2025-12-31 $43,574,823 569,680
2025-09-30 $29,936,657 576,370
2025-06-30 $25,420,497 588,710
2025-03-31 $31,569,324 913,200
2024-12-31 $25,121,320 915,500
2024-09-30 $23,085,193 906,724
2024-06-30 $23,478,377 926,900
2024-03-31 $28,669,951 927,230
2023-12-31 $38,109,280 944,000
2023-09-30 $24,753,519 938,700
2023-06-30 $11,972,782 696,092
2023-03-31 $12,269,067 739,992
2022-12-31 $6,959,285 913,292
2022-09-30 $10,315,036 1,037,730
2022-06-30 $9,559,696 1,052,830
2022-03-31 $11,493,352 1,132,350
2021-12-31 $17,526,343 1,050,740
2021-09-30 $21,600,508 460,860
2021-06-30 $27,240,585 446,860
2021-03-31 $21,882,599 355,237